Company news
ImmuPharma plc news in 2021
ImmuPharma plc's news releases, calls and decks from 2021, newest first.
Subscriptions and Placing to raise £3.55 million
December 20, 2021
Collaboration with Imperial College London
November 29, 2021
Euronext Delisting
October 1, 2021
Prof. Sylviane Muller awarded 'Legion d'honneur'
September 30, 2021
Interim Results for the 6months ended 30 June 2021
September 29, 2021
Director/PDMR Shareholding
August 24, 2021
Notification of Major Holdings
August 17, 2021
FDA approves the LupzuorT PK study
August 12, 2021
Board Changes
July 30, 2021
Board Appointment
July 16, 2021
2021 Result of annual general meeting -replacement
June 28, 2021
Update: LupzuorT PK study
June 24, 2021
Notice of AGM and posting of Report & Accounts
June 2, 2021
Director Retirement
May 24, 2021
Update- scheduled Phase 3 trials in lupus patients
February 9, 2021